Combination therapy for the treatment of acute myelogenous leukemia

摘要

(3-methoxy-4- [4- (4-methylpiperazin-1-yl) piperidin- 1 -yl] phenyl} amino) -5- (tetrahydro- Pyrazine-2-carboxamide or a salt thereof, and 4-amino-1 -? - D-ribofuranosyl-1,3,5-triazine-2 (1H) Methods, uses and compositions are provided for the treatment of acute myelogenous leukemia, including a therapeutically effective combination of salts.